Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project

Emmerton, L, Shaw, J and Kheir, N (2003) Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. Journal of Clinical Pharmacy And Therapeutics, 28 5: 395-402. doi:10.1046/j.0269-4727.2003.00507.x

Author Emmerton, L
Shaw, J
Kheir, N
Title Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project
Journal name Journal of Clinical Pharmacy And Therapeutics   Check publisher's open access policy
ISSN 0269-4727
Publication date 2003
Sub-type Article (original research)
DOI 10.1046/j.0269-4727.2003.00507.x
Volume 28
Issue 5
Start page 395
End page 402
Total pages 8
Editor A. Po
M. Kendall
Place of publication UK
Publisher Blackwell
Collection year 2003
Language eng
Subject C1
321217 Health Counselling
730110 Respiratory system and diseases (incl. asthma)
111717 Primary Health Care
110203 Respiratory Diseases
Abstract Background: Pharmaceutical care services became recognized in New Zealand in the mid-1990s, albeit with limited evidence of the acceptability and effectiveness of the model. An asthma-specific pharmaceutical care service was trialled in southern New Zealand, based on a 'problem-action-outcome' method, with pharmacists adopting a patient-centred, outcome-focused approach with multidisciplinary consultation. Objective: To report on the implementation and outcomes of a specialist asthma service offered by community pharmacists. Design: Pharmacists in five pharmacies, servicing predominantly rural, established clientele, received training in the asthma service and research documentation. Ten patients per pharmacy were recruited in each year (years 1 and 2) of the study. The patients were entered into the study in cohorts of five per pharmacy twice yearly, with year 2 mirroring year 1. The phase-in design minimized the impact on the pharmacists. The patients acted as their own controls. All patients received individualized care and had approximately monthly consultations with the pharmacist, with clinical and quality of life (QoL) monitoring. Results: A total of 100 patients were recruited. On average, 4.3 medication-related problems were identified per patient; two-thirds of them were compliance-related. The most common interventions were revision of patients' asthma action plans, referral and medication counselling. Clinical outcomes included reduced bronchodilator use and improved symptom control in around two-thirds of patients. Asthma-specific QoL changes were more positive and correlated well with clinical indicators. Conclusion: Further research is warranted to integrate this service into daily practice. Clinical outcomes were generally positive and supported by QoL indicators. Characteristics of New Zealand practice and this sample of pharmacies may limit the generalizability of these findings.
Keyword Pharmacology & Pharmacy
Community Pharmacy
Pharmaceutical Care
Quality Of Life
Specialist Service
Q-Index Code C1

Document type: Journal Article
Sub-type: Article (original research)
Collections: Excellence in Research Australia (ERA) - Collection
2004 Higher Education Research Data Collection
School of Pharmacy Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 26 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 35 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 15 Aug 2007, 02:13:49 EST